Clinical Trial

Clinical Study of CVL006 Combination With 9MW2821

Name: Clinical Study of CVL006 Combination With 9MW2821 — clinical trial record (NCT07615660)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CVL006-T1003

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study is a multi-center, open-label, dose-escalation and dose-optimized phase I/II clinical trial. Objective: To determine the safety, tolerability, PK characteristics and preliminary efficacy data of CVL006 combined with 9MW821 patients with advanced solid tumors.

Trial Details

NCT Number	NCT07615660
Lead Sponsor	Convalife (Shanghai) Co., Ltd.
Conditions	Advanced Solid Tumor
Enrollment	108 participants
Start Date	2026-05-15
Primary Completion	2029-04-30 (estimated)
Study Completion	2029-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-29